Neogen Statistics
NASDAQ: NEOGHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
11.25-0.43 (-3.68%)
Market open · Delayed 15 min · as of Oct 8, 9:34 AM ET
Neogen by the numbers
Neogen has a market capitalization of $2.45 billion based on 218.11M shares outstanding. With trailing EPS of $-0.26, Neogen is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 6.8% below its 50-day average and 11.7% above its 200-day average.
Average daily trading volume is 3.02M shares, or about $34.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NEOG valuation vs. peer median
| Metric | NEOG | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.45B | $596.40M | +311% |
| Avg. volume | 3.02M | 1.36M | +123% |
Peer median across 8 companies: CLDX, NTLA, QDEL, ACHV, TKNO, MYGN, NNNN, IMDX.
Valuation
- Market cap
- $2.45B
- Forward P/E
- 29.61
- Price / sales (latest FY)
- 2.82
- EPS (TTM)
- $-0.26
- Shares outstanding
- 218.11M
Price and trading
- Previous close
- 11.68
- Open
- 11.50
- Day range
- 11.23 – 11.58
- 52-week range
- 5.37 – 14.26
- 52-week change
- +108.94%
- Beta
- —
- Volume
- 216.09K
- Average volume
- 3.02M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 6, 2026
Additional statistics
- Market Cap
- 2.45B
- Forward Pe
- 29.61
- Eps
- -0.26
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 14.26
- Week52 Low
- 5.37
- Avg Volume
- 3.02M
- Shares Outstanding
- 218.11M
- Ma50
- 12.07
- Ma200
- 10.07
- Earnings Date
- Oct 6, 2026
- Pct From52w High
- -21.11%
- Pct From52w Low
- 109.50%